← JAMA Network
JAMA Network
JAMA Neurology : Gefurulimab and Generalized Myasthenia Gravis
00:16:42
Interview with Kelly G. Gwathmey, MD, author of Efficacy and Safety of Gefurulimab in Generalized Myasthenia Gravis: The PREVAIL Phase 3 Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD. Related Content: